Company profile: DFE Pharma
1.1 - Company Overview
Company description
- Provider of excipient solutions for pharmaceutical, biopharmaceutical, and nutraceutical industries, developing, producing, and supplying functional excipients used as fillers, binders, disintegrants, and stabilizers. Offers BioHale excipients to stabilize biologics across parenteral, inhalation, oral, and ophthalmic routes, an online formulation tool, and technical, regulatory, quality, and formulation support.
Products and services
- BioHale®: Portfolio of excipients, including BioHale® Sucrose and BioHale® Trehalose Dihydrate, engineered for stabilizing biologics across parenteral, inhalation, oral, and ophthalmic administration routes
- Excipients: DFE Pharma develops, produces, and supplies functional excipients serving as fillers, binders, disintegrants, and stabilizers in pharmaceutical formulations for pharmaceutical, biopharmaceutical, and nutraceutical applications
- Formulation Tool: Online tool that helps users identify the most optimal formulation for their Active Pharmaceutical Ingredient via guided or expert modes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to DFE Pharma
Southwood Research
HQ: United Kingdom
Website
- Description: Provider of pre-approval regulatory science services to the pharmaceutical and biotech industries, focusing on the science behind each product and delivering strategic clinical and regulatory insight.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Southwood Research company profile →
Boca Biolistics
HQ: United States
Website
- Description: Provider of hybrid CRO and biobank services, delivering human biospecimens across oncology and other diseases; end-to-end contract research to support development and market approval of diagnostic technologies; CLIA-certified, CAP-accredited reference lab testing; COVID-19 serology and PCR; and oncology research solutions combining clinical research, data analytics, and industry leading clinical and molecular datasets to enable precision medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Boca Biolistics company profile →
Cellipont
HQ: United States
Website
- Description: Provider of cell therapy CDMO services specializing in cell therapy development and small-to-large batch production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellipont company profile →
Eurofins
HQ: Luxembourg
Website
- Description: Provider of analytical testing and support services across pharmaceutical, food, environmental, and consumer products industries, including clinical diagnostics (sample collection, testing, counseling), environmental testing of water, air, soil and waste, cosmetics and personal care compliance testing, E&E product safety and approvals, maritime pollution and fuel/oil testing, and microbiological testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eurofins company profile →
TKL Research
HQ: United States
Website
- Description: Provider of a fully integrated network of clinical research centers serving pharmaceutical, biotechnology, medical device, and consumer healthcare industries, offering inpatient and outpatient capabilities, including two purpose-built phase I clinical pharmacology units and five outpatient clinics equipped for phase II–IV clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TKL Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for DFE Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to DFE Pharma
2.2 - Growth funds investing in similar companies to DFE Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for DFE Pharma
4.2 - Public trading comparable groups for DFE Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →